問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Veterans General Hospital (在職)

Division of Neurology

更新時間:2023-11-03

李宜中Lee, Yi-Chun
  • Principal Investigator
  • Clinical Trial Experience (year) 21 years 10 個月

篩選

List

32Cases

2021-02-03 - 2024-01-25

Phase III

An open-label extension study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis
  • Condition/Disease

    generalized myasthenia gravis

  • Test Drug

    Rozanolixizumab

Participate Sites
5Sites

Not yet recruiting3Sites

Recruiting1Sites

Study ended1Sites

2016-11-16 - 2020-01-31

Phase III

A multicenter, randomized, double-blind, placebo-controlled, phase 3 study to evaluate the efficacy and safety of SA237 as monotherapy in patients with neuromyelitis optica (NMO) and NMO spectrum disorder (NMOSD).
  • Condition/Disease

    neuromyelitis optica (NMO) and NMO spectrum disorder (NMOSD)

  • Test Drug

    SA237

Participate Sites
3Sites

Terminated2Sites

Study ended1Sites

1 2 3 4